论文部分内容阅读
目的:探讨慢性脑血管功能不全的治疗方法和临床疗效。方法:选取2013年6月至2015年1月于我院就诊的慢性脑血管功能不全患者共78例,将患者随机分为两组:观察组和对照组患者各39例,对照组患者入院之后进行常规治疗;观察组患者在对照组常规治疗的基础之上,再联合尼麦角林进行治疗,对治疗后患者的总有效率进行统计分析。结果:观察组的总有效率为94.87%,明显高于对照组的84.61%,两组治疗效果具有明显差异,P<0.05。结论:采用常规治疗结合尼麦角林治疗可以及时的治疗慢性脑血管功能不全的患者,有效的改善脑组织供血、供氧不足、记忆力退化和动脉硬化的症状。在临床医学上具有很明显的临床效果,值得在临床上大力推广。
Objective: To explore the treatment of chronic cerebrovascular insufficiency and clinical efficacy. Methods: A total of 78 patients with chronic cerebrovascular insufficiency who visited our hospital from June 2013 to January 2015 were selected and randomly divided into two groups: 39 cases in observation group and control group, and 39 cases in control group after admission The patients in the observation group were treated with nicergoline on the basis of routine treatment in the control group, and the total effective rate of the patients after treatment was statistically analyzed. Results: The total effective rate of the observation group was 94.87%, which was significantly higher than that of the control group (84.61%). There was significant difference between the two groups (P <0.05). Conclusion: The conventional treatment combined with nicergoline can effectively treat patients with chronic cerebrovascular insufficiency and effectively improve the cerebral blood supply, oxygen deficiency, memory deterioration and arteriosclerosis symptoms. In clinical medicine has a very obvious clinical effect, it is worth to clinically promote.